Cargando…

Arrestin Domain Containing 3 Reverses Epithelial to Mesenchymal Transition and Chemo-Resistance of TNBC Cells by Up-Regulating Expression of miR-200b

Our previous studies demonstrated the importance of arrestin domain containing 3 (ARRDC3), a metastasis suppressor, in inhibiting invasive and metastatic potential of triple negative breast cancer (TNBC) in vitro and in vivo. However, little is known about ARRDC3 mediated transcriptional control and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soung, Young Hwa, Chung, Heesung, Yan, Cecilia, Ju, Jingfang, Chung, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679179/ https://www.ncbi.nlm.nih.gov/pubmed/31295851 http://dx.doi.org/10.3390/cells8070692

Ejemplares similares

The Role of Arrestin Domain-Containing 3 in Regulating Endocytic Recycling and Extracellular Vesicle Sorting of Integrin β4 in Breast Cancer
por: Soung, Young Hwa, et al.
Publicado: (2018)

Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers
por: Soung, Young Hwa, et al.
Publicado: (2020)

MicroRNA miR-124-3p suppresses proliferation and epithelial–mesenchymal transition of hepatocellular carcinoma via ARRDC1 (arrestin domain containing 1)
por: Zhao, Qiannan, et al.
Publicado: (2022)

The arrestin-domain containing protein AdcA is a response element to stress
por: Habourdin, Clémence, et al.
Publicado: (2013)

The microRNA-200 Family Regulates Epithelial to Mesenchymal Transition
por: Paterson, Emily L., et al.
Publicado: (2008)

Tamoxifen reverses epithelial–mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells
por: Wang, Qian, et al.
Publicado: (2017)

Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma
por: Zhou, Yang, et al.
Publicado: (2022)

The Tetraindole SK228 Reverses the Epithelial-to-Mesenchymal Transition of Breast Cancer Cells by Up-Regulating Members of the miR-200 Family
por: Wang, Chie-Hong, et al.
Publicado: (2014)

Notch1 Affects Chemo-resistance Through Regulating Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian cancer cells
por: Qian, Xue-qian, et al.
Publicado: (2020)

Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease
por: Ogawa, Masahiro, et al.
Publicado: (2019)

Dynamics and plasticity of the epithelial to mesenchymal transition induced by miR-200 family inhibition
por: Haraguchi, Takeshi, et al.
Publicado: (2016)

The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition
por: Choi, Pui-Wah, et al.
Publicado: (2017)

MicroRNA 200b promotes mesenchymal-to-epithelial transition in anaplastic thyroid carcinoma
por: Tamagawa, Shunji, et al.
Publicado: (2020)

Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer
por: Ryu, Ji-Won, et al.
Publicado: (2023)

Up-regulated miR155 Reverses the Epithelial-mesenchymal Transition Induced by EGF and Increases Chemo-sensitivity to Cisplatin in Human Caski Cervical Cancer Cells
por: Lei, Cui, et al.
Publicado: (2012)

Canine Mammary Cancer Stem Cells are Radio- and Chemo-Resistant and Exhibit an Epithelial-Mesenchymal Transition Phenotype
por: Pang, Lisa Y., et al.
Publicado: (2011)

Arrestin domain containing 3 promotes Helicobacter pylori–associated gastritis by regulating protease-activated receptor 1
por: Liu, Yu-gang, et al.
Publicado: (2020)

Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues
por: Hosokawa, Yuko, et al.
Publicado: (2017)

Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell
por: Lu, Yuhua, et al.
Publicado: (2014)

EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo−/radioresistance in nasopharyngeal carcinoma
por: Lu, Yaoyong, et al.
Publicado: (2019)

Epithelial down‐regulation of the miR‐200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition
por: Mehta, Shameer J., et al.
Publicado: (2018)

Boolean modeling of mechanosensitive epithelial to mesenchymal transition and its reversal
por: Sullivan, Emmalee, et al.
Publicado: (2023)

Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
por: Song, Qing, et al.
Publicado: (2020)

β-Arrestin1 Promotes Colorectal Cancer Metastasis Through GSK-3β/β-Catenin Signaling- Mediated Epithelial-to-Mesenchymal Transition
por: Song, Qing, et al.
Publicado: (2021)

miR-200c regulates crizotinib-resistant ALK-positive lung cancer cells by reversing epithelial-mesenchymal transition via targeting ZEB1
por: Gao, Hai-Xiang, et al.
Publicado: (2016)

Decitabine reverses TGF-β1-induced epithelial–mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis
por: Zhang, Nan, et al.
Publicado: (2017)

V-set and immunoglobulin domain containing 1 (VSIG1) as an emerging target for epithelial–mesenchymal transition of gastric cancer
por: Satala, Catalin-Bogdan, et al.
Publicado: (2022)

Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis
por: Davalos, V, et al.
Publicado: (2012)

miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition
por: Sulaiman, Siti A., et al.
Publicado: (2016)

miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas
por: Tseng, Jill H., et al.
Publicado: (2017)

Effect of Huai Qi Huang on Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells through miR-200a
por: Pu, Jinyun, et al.
Publicado: (2016)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

Corrigendum: Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer
por: Song, Qing, et al.
Publicado: (2022)

LC–MS Based Lipidomics Depict Phosphatidylethanolamine as Biomarkers of TNBC MDA-MB-231 over nTNBC MCF-7 Cells
por: Estrada-Pérez, Alan Rubén, et al.
Publicado: (2022)

Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC
por: Tan, Renbo, et al.
Publicado: (2020)

Decitabine reverses TGF-β1-induced epithelial–mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis [Corrigendum]
Publicado: (2017)

Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
por: Chen, Chen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rhjqvbemhd6oa65k2clt3slffi